Pathology of encapsulating peritoneal sclerosis

Peritoneal Dialysis International

Volumn 25, Issue SUPPL. 4, 2005, Pages

  Honda, Kazuho ^a   Oda, Hideaki ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Adhesion; Encapsulating peritoneal sclerosis; EPS; Fibrin; Fibroblast; Fibrosis; Peritoneal biopsy; Vasculopathy

Indexed keywords

CORTICOSTEROID; FIBRIN; PREDNISOLONE;

ADULT; ASCITES; AUTOPSY; CARDIOMEGALY; CASE REPORT; CELL ACTIVATION; CELL PROLIFERATION; CLINICAL FEATURE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; DEATH; DISEASE ASSOCIATION; EARLY DIAGNOSIS; EDEMA; ENTEROPATHY; FIBRIN DEPOSITION; FIBROBLAST; FIBROSIS; HEART INFARCTION; HEMOPERITONEUM; HISTOPATHOLOGY; HOSPITALIZATION; HUMAN; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LAPAROSCOPY; MALE; MICROVASCULATURE; PATHOGENESIS; PERITONEAL BIOPSY; PERITONEUM EXUDATE; PHENOTYPE; PNEUMONIA; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SCLEROSING PERITONITIS; SEPSIS;

EID: 27744459992     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686080502504s04     Document Type: Review

References (21)

1. Nomoto Y, Kawaguchi Y, Kubo H, Hirano H, Sakai S, Kurokawa K. Sclerosing encapsulating peritonitis in patients undergoing continuous ambulatory peritoneal dialysis: a report of the Japanese Sclerosing Encapsulating Peritonitis Study Group. Am J Kidney Dis 1996; 28:420-7.
2. Kawaguchi Y, Kawanishi H, Mujais S, Topley N, Oreopoulos DG. Encapsulating peritoneal sclerosis: definition, etiology, diagnosis, and treatment. International Society for Peritoneal Dialysis Ad Hoc Committee on Ultrafiltration Management in Peritoneal Dialysis. Perit Dial Int 2000; 20(Suppl 4):S43-55.
3. Di Paolo N, Sacchi G, De Mia M, Gaggiotti E, Capotondo L, Rossi P. et al. Morphology of the peritoneal membrane during continuous ambulatory peritoneal dialysis. Nephron 1986; 44:204-11.
4. Gotloib L, Shostak A. Ultrastructural morphology of the peritoneum: new findings and speculations on transfer of solutes and water during peritoneal dialysis. Perit Dial Bull 1987; 7:119-29.
5. Dobbie JW. Pathogenesis of peritoneal fibrosing syndromes (sclerosing peritonitis) in peritoneal dialysis. Perit Dial Int 1992; 12:14-27.
6. Dobbie JW, Anderson JD, Hind C. Long-term effects of peritoneal dialysis on peritoneal morphology. Pent Dial Int 1994; 14(Suppl 3):S16-20.
7. Honda K, Nitta K, Horita S, Tsukada M, Itabashi M, Nihei H, et al. Histologic criteria for diagnosing encapsulating peritoneal sclerosis in continuous ambulatory peritoneal dialysis patients. Adv Perit Dial 2003; 19:169-75.
8. Gotloib L, Bar-Sella P. Shostak A. Reduplicated basal lamina of small venules and mesothelium of human parietal peritoneum: ultrastructural changes of reduplicated peritoneal basement membrane. Perit Dial Bull 1985; 5:212-15.
9. Di Paolo N, Sacchi G. Peritoneal vascular changes in continuous ambulatory peritoneal dialysis (CAPD): an in vivo model for the study of diabetic microangiopathy. Perit Dial Int 1989; 9:41-5.
10. Honda K, Nitta K, Horita S, Yumura W, Nihei H. Morphological changes in the penitoneal vasculature of patients on CAPD with ultrafiltration failure. Nephron 1996; 72: 171-6.
11. Mateijsen MA, van der Wal AC, Hendriks PM, Zweers MM, Mulder J, Struijk DG, et al. Vascular and interstitial changes in the peritoneum of CAPD patients with penitoneal sclerosis. Perit Dial Int 1999; 19:517-25.
12. Combet S, Miyata T, Moulin P, Pouthier B, Goffin E, Devuyst O. Vascular proliferation and enhanced expression of endothelial nitric oxide synthase in human peritoneum exposed to long-term peritoneal dialysis. J Am Soc Nephrol 2000; 11:717-28.
13. Williams JD, Craig KJ, Topley N, Von Ruhland C, Fallon M, Newman GR, et al., for the Peritoneal Biopsy Study Group. Morphological changes in the peritoneal membrane of patients with renal disease. J Am Soc Nephrol 2002; 13: 470-9.
14. Hendriks PM, Ho-dac-Pannekeet MM, van Gulik TM, Struijk DG, Phoa SS, Sie L, et al. Peritoneal sclerosis in chronic peritoneal dialysis patients: analysis of clinical presentation, risk factors, and peritoneal transport kinetics. Perit Dial Int 1997; 17:136-43.
15. Krediet RI, Lindholm B, Rippe B. Pathophysiology of peritoneal membrane failure. Perit Dial Int 2000; 20(Suppl4): S22-42.
16. Plum J, Hermann S, Fusshöller A, Schoenicke G, Donner A, Röhrborn A, et al. Peritoneal sclerosis in peritoneal dialysis patients related to dialysis settings and peritoneal transport properties. Kidney Int 2001; 59(Suppl 78):42-7.
17. Margetts PJ, Bonniaud P. Basic mechanisms and clinical implications of peritoneal fibrosis. Perit Dial Int 2003; 23:530-41.
18. Mitchell RA, Liao H, Chesney J, Fingerle-Rowson G, Baugh J, David J, et al. Macrophage migration inhibitory factor (MIF) sustains macrophage proinflammatory function by inhibiting p53: regulatory role in the innate immune response. Proc Natl Acad Sci 2002; 99:345-50.
19. Strutz F, Zeisberg M, Hemmerlein B, Sattler B, Hummel K, Becker V, et al. Basic fibroblast growth factor expression is increased in human renal fibrogenesis and may mediate autocrine fibroblast proliferation. Kidney Int 2000; 57:1521-38.
20. Saed GM, Diamond MP. Apoptosis and proliferation of human peritoneal fibroblasts in response to hypoxia. Fertil Steril 2002; 78:137-43.
21. Zhang G, Oldroyd SD, Huang LH, Yang B, Li Y, Ye R, et al. Role of apoptosis and Bcl-2/Bax in the development of tubulointerstitial fibrosis during experimental obstructive nephropathy. Exp Nephrol 2001; 9:71-80.